LTR Pharma Limited (AU:LTP) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
LTR Pharma Limited has announced the issuance of 300,000 new options set to expire on December 2, 2028. These unquoted securities are part of an employee incentive scheme and will not be listed on the ASX. This move reflects the company’s strategy to incentivize its workforce and potentially strengthen its market position.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.